Shang, Z., Li, Y., Zhang, M., Tian, J., Han, R., Shyr, C., . . . Chang, C. (2015). Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9(®) enhances BCG efficacy to better suppress bladder cancer progression. Mol Cancer Ther.
Chicago Stili AlıntıShang, Zhiqun, et al. "Anti-androgen Therapy With Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9(®) Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression." Mol Cancer Ther 2015.
MLA AlıntıShang, Zhiqun, et al. "Anti-androgen Therapy With Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9(®) Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression." Mol Cancer Ther 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..